A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma.
Qureshi S, Khandelwal R, Madhavi M, Khurana N, Gupta N, Choudhary SK, Suresh RA, Hazarika L, Srija CD, Sharma K, Hindala MR, Hussain T, Nayarisseri A, Singh SK.
Qureshi S, et al. Among authors: khandelwal r.
Curr Top Med Chem. 2021;21(9):790-818. doi: 10.2174/1568026621666210119112336.
Curr Top Med Chem. 2021.
PMID: 33463471